Gianfranco Vitiello

Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study

Serena Colafrancesco, Roberta Priori, Guido Valesini et al. · Frontiers in Pharmacology · 2017 · 106 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +16

A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study

Antonio Vitale, Antonella Insalaco, Paolo Sfriso et al. · Frontiers in Pharmacology · 2016 · 88 citations · Full text

Medicine, Immunology, Pharmacotherapy +12

Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study

Jurgen Sota, Antonio Vitale, Antonella Insalaco et al. · Clinical Rheumatology · 2018 · 82 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +17

ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study

Francesco Menzella, Elena Bargagli, Maria Aliani et al. · Respiratory Research · 2022 · 47 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Long-Term Retention Rate of Anakinra in Adult Onset Still’s Disease and Predictive Factors for Treatment Response

Antonio Vitale, Giulio Cavalli, Serena Colafrancesco et al. · Frontiers in Pharmacology · 2019 · 40 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17